• 1. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 2. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 3. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 4. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 5. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Phenylpyrazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Phenylpyrazoles

Introduction to 3-(Aminomethyl)-1-methyl-5-phenyl-1H-pyrazole (CAS No. 869901-12-2)

3-(Aminomethyl)-1-methyl-5-phenyl-1H-pyrazole is a significant compound in the field of pharmaceutical chemistry, characterized by its unique structural and functional properties. This heterocyclic compound, identified by the CAS number 869901-12-2, has garnered attention due to its potential applications in medicinal chemistry and drug development. The molecular structure of this compound consists of a pyrazole core substituted with an aminomethyl group, a methyl group, and a phenyl group, which contribute to its diverse chemical reactivity and biological activity.

The aminomethyl functional group at the 3-position of the pyrazole ring is particularly noteworthy, as it introduces a nucleophilic center that can participate in various chemical transformations. This feature makes 3-(Aminomethyl)-1-methyl-5-phenyl-1H-pyrazole a valuable intermediate in the synthesis of more complex molecules. Additionally, the presence of the methyl and phenyl substituents enhances the compound's lipophilicity and binding affinity, which are critical factors in drug design.

Recent advancements in pharmaceutical research have highlighted the importance of pyrazole derivatives in developing novel therapeutic agents. Pyrazoles are known for their broad spectrum of biological activities, including anti-inflammatory, antimicrobial, and anticancer properties. The specific substitution pattern in 3-(Aminomethyl)-1-methyl-5-phenyl-1H-pyrazole may confer unique pharmacological effects, making it a promising candidate for further investigation.

In vitro studies have demonstrated that this compound exhibits notable interactions with biological targets, suggesting its potential as a lead molecule for drug discovery. The aminomethyl group, in particular, has been shown to facilitate the formation of hydrogen bonds and ionic interactions with biological receptors, enhancing binding affinity. These interactions are crucial for the development of drugs that can effectively modulate biological pathways.

The synthesis of 3-(Aminomethyl)-1-methyl-5-phenyl-1H-pyrazole involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Advanced synthetic methodologies, such as palladium-catalyzed cross-coupling reactions and transition-metal-catalyzed hydrogenations, have been employed to construct the desired molecular framework efficiently. These synthetic strategies not only improve the accessibility of the compound but also allow for modifications that can enhance its pharmacological properties.

One of the most exciting aspects of 3-(Aminomethyl)-1-methyl-5-phenyl-1H-pyrazole is its versatility in drug design. The combination of the pyrazole core with various substituents provides a scaffold that can be tailored to target specific diseases. For instance, modifications at the 5-position can influence the compound's solubility and metabolic stability, while changes at the 3-position can alter its binding affinity to biological targets. This flexibility makes it an attractive candidate for structure-based drug design approaches.

Current research is exploring the potential applications of this compound in treating neurological disorders. Pyrazole derivatives have shown promise in modulating neurotransmitter systems, which could make them effective against conditions such as Alzheimer's disease and Parkinson's disease. The aminomethyl group in 3-(Aminomethyl)-1-methyl-5-phenyl-1H-pyrazole may play a key role in interacting with neuronal receptors, potentially leading to novel therapeutic strategies.

Another area of interest is the use of this compound in anticancer research. Studies have indicated that pyrazole derivatives can inhibit key enzymes involved in tumor growth and proliferation. The structural features of 3-(Aminomethyl)-1-methyl-5-phenyl-1H-pyrazole, including its lipophilic nature and ability to form stable complexes with biological targets, make it a promising candidate for developing anticancer agents.

The development of new drugs often involves rigorous testing to evaluate their safety and efficacy. Preclinical studies are essential to assess the pharmacokinetic properties, toxicity profiles, and therapeutic potential of compounds like 3-(Aminomethyl)-1-methyl-5-phenyl-1H-pyrazole. These studies provide critical data that guide further development efforts and help ensure that only safe and effective drugs reach clinical trials.

In conclusion, 3-(Aminomethyl)-1-methyl-5-phenyl-1H-pyrazole (CAS No. 869901-12-2) is a versatile compound with significant potential in pharmaceutical research. Its unique structural features and biological activities make it an attractive candidate for developing novel therapeutic agents targeting various diseases. Continued research into this compound will likely uncover new applications and reinforce its importance in drug discovery efforts.

• 10250-60-9(1,5-dimethyl-3-phenyl-1H-pyrazole)
• 10250-58-5(1,3-dimethyl-5-phenyl-1H-pyrazole)
• 934570-45-3(3-(1-methyl-1H-pyrazol-5-yl)benzylamine)
• 876728-39-1((1-methyl-3-phenyl-1H-pyrazol-5-yl)methanamine)
• 3463-27-2(1-Methyl-5-phenyl-1H-pyrazole)
• 915707-40-3(4-(1-methyl-1H-pyrazol-3-yl)benzylamine)
• 864068-98-4(1H-Pyrazole-5-methanamine,N,1-dimethyl-3-phenyl-)
• 49866-87-7(Difenzoquat)
• 73387-56-1(1H-Pyrazole, 1-methyl-5-(4-methylphenyl)-)
• 56119-92-7(1H-Pyrazolium, 1,2-dimethyl-3,5-diphenyl-, hydroxide (1:1))